Skip to main content
Our Work

A National Strategy for Cancer Control in the United States

Completed

Topics

Challenges of cancer control start with complex nature of cancers themselves. The burdens of cancers are broad and diverse. Cancer control efforts in the U.S are complex, involving more than a dozen federal agencies, 65 states and territories, Many nonprofit organizations and for-profit companies. The National Academies with support from the American Cancer Society, Centers for Disease Control and Prevention, and the National Cancer Institute initiated a consensus study to examine cancer control efforts in the U.S and recommend a national strategy to reduce the incidence, morbidity, and mortality from cancer and to improve quality of life for cancer survivors.

About Past Events

Description

An ad hoc committee under the auspices of the National Academies of Sciences, Engineering, and Medicine will examine cancer control efforts in the United States and recommend a national strategy to reduce the incidence, morbidity, and mortality from cancer and to improve quality of life for cancer survivors.

The committee will review trends in cancer cases and outcomes in the United States as well as existing cancer control programs and initiatives across the cancer care continuum. Based on that review, the committee will consider potential actions to:

· Establish comprehensive national goals for cancer control.

· Identify potential mechanisms to evaluate and advance progress toward these goals.

· Identify challenges to achieving these goals and highlight knowledge gaps that impede progress in cancer control

· Foster collaboration and coordination among key stakeholders, clarifying roles in cancer control efforts, and to build on existing efforts and to develop and implement plans of action to overcome challenges.

· Prioritize cancer control interventions that have the potential to achieve significant progress in improving population health and reducing health disparities.

The committee will issue a report with findings and recommendations to achieve progress in developing and implementing a national cancer control strategy.

Contributors

Committee

Chair

Member

Member

Member

Member

Member

Member

Member

Member

Member

Member

Member

Member

Member

Member

Member

Download all bios

Conflict of Interest Disclosure

Disclosure of Conflict of Interest: George Poste

The conflict of interest policy of the National Academies of Sciences, Engineering, and Medicine (http://www.nationalacademies.org/coi) prohibits the appointment of an individual to a committee authoring a Consensus Study Report if the individual has a conflict of interest that is relevant to the task to be performed. An exception to this prohibition is permitted if the National Academies determines that the conflict is unavoidable and the conflict is publicly disclosed. A determination of a conflict of interest for an individual is not an assessment of that individual's actual behavior or character or ability to act objectively despite the conflicting interest.

George Poste has a conflict of interest in relation to his service on the Committee on a National Strategy for Cancer Control in the United States because he serves on the board of directors of Exelexis, Inc. and Caris Life Sciences.

The National Academies has concluded that in order for the committee to accomplish the tasks for which it was established, its membership must include at least one person with current industry experience in drugs, devices, and vaccines development. As described in his biographical summary, Dr. Poste has extensive current experience in multiple industry sectors that focus on developing preventive, diagnostic, and therapeutic interventions for cancer.

The National Academies has determined that the experience and expertise of Dr. Poste is needed for the committee to accomplish the task for which it has been established. The National Academies could not find another available individual with the equivalent experience and expertise who does not have a conflict of interest. Therefore, the National Academies has concluded that the conflict is unavoidable.

The National Academies believes that Dr. George Poste can serve effectively as a member of the committee, and the committee can produce an objective report, taking into account the composition of the committee, the work to be performed, and the procedures to be followed in completing the study.

Sponsors

American Cancer Society

Centers for Disease Control and Prevention (CDC)

National Institutes of Health

Staff

Guru Madhavan

Lead

Francis Amankwah

Annalee Espinosa Gonzales

More like this

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.